Can serum catecholamine at 1 week after I-131 MIBG therapy predict response in malignant pheochromocytoma?

被引：0
|
作者：
Higuchi, T. [1 ]
Oriuchi, N. [1 ]
Arisaka, Y. [1 ]
Miyashita, G. [2 ]
Ishikia, T. [2 ]
Hanaoka, H. [3 ]
Otake, H. [4 ]
Koyama, K. [5 ]
Endo, K. [1 ]
机构：
[1] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma 371, Japan
[2] Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, Maebashi, Gunma 371, Japan
[3] Gunma Univ, Grad Sch Med, Dept Bioimaging Informat Anal, Maebashi, Gunma 371, Japan
[4] Gunma Univ Hosp, Dept Radiol, Maebashi, Gunma, Japan
[5] Gunma Prefectural Cardiovasc Ctr, Dept Radiol, Maebashi, Gunma, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S418 / S418
页数：1
相关论文
共 50 条
  • [1] I-131 MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
    Gedik, G. K.
    Hoefnagel, C. A.
    Bais, E.
    Olmos, R. A. Valdes
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S241 - S241
  • [2] MALIGNANT PHEOCHROMOCYTOMA TREATED BY I-131 MIBG
    MCDOUGALL, IR
    JOURNAL OF NUCLEAR MEDICINE, 1984, 25 (02) : 249 - 251
  • [3] THERAPY OF MALIGNANT PHEOCHROMOCYTOMA WITH I-131 META-IODOBENZYLGUANIDINE (MIBG)
    MCEWAN, AJ
    BLAKE, G
    HALL, VL
    ACKERY, DM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1985, 11 (2-3): : A17 - A17
  • [4] High dose I-131 mIBG therapy in patients with malignant pheochromocytoma.
    McEwan, AJB
    Amyotte, G
    Morin, C
    McGowan, DG
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 1066 - 1066
  • [5] Norepinephrine released in the serum after I-131 MIBG therapy to malignant pheochromocytoma induces FDG uptake in brown adipose tissue
    Higuchi, T.
    Oriuchi, N.
    Miyakubo, M.
    Ishikita, T.
    Koyama, Y.
    Tian, M.
    Otake, H.
    Koyama, K.
    Suzuki, H.
    Endo, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S156 - S156
  • [6] Finding an effective method to predict response to I-131 mIBG therapy
    Buscombe, J
    Sultana, S
    Jones, J
    Purfield, D
    Caplin, M
    Hilson, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S479 - S479
  • [7] The Prognostic Value of Hormonal Responses after Initial Low Dose I-131 MIBG Therapy in Patients with Malignant Pheochromocytoma and Paraganglioma
    Wakabayashi, H.
    Taki, J.
    Inaki, A.
    Nakamura, A.
    Kayano, D.
    Fukuoka, M.
    Matsuo, S.
    Nakajima, K.
    Kinuya, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S316 - S317
  • [8] Repeated I-131-MIBG Therapy in Patients with Malignant Pheochromocytoma
    Lam, M. G. E. H.
    Lips, C. J. M.
    Jager, P. L.
    Lentjes, E. G. W. M.
    van Rijk, P. P.
    de Klerk, J. M. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S201 - S201
  • [9] I-131 MIBG therapy has been used as the first line therapy in pheochromocytoma
    Dhingra, Jitesh
    Halkar, Raghuveer
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [10] Clinical Dosimetry Tool Implementation of I-131 MIBG Therapy for Pheochromocytoma and Paraganglioma
    Franco, R. Perez
    Pugachev, A.
    MEDICAL PHYSICS, 2020, 47 (06) : E519 - E519
12345